Alsace BioValley is a cluster which federates in Alsace, all actors in life sciences and health (companies, research centers, hospitals, training institutions and universities). It is a unique and effective gateway to develop projects for bio-business, therapeutic innovation and employment. Alsace Bio Valley is also one of 71 clusters labelled by the French government in 2005 to support innovation excellence in France. Alsace BioValley accompanies the growth of players in the field of Life-Health in the territory of Alsace and beyond borders.
For more information about Alsace BioValley, please go to: www.alsace-biovalley.com
Fonded in 1991, BIOQuébec, the largest network of bio-industries and life science in Canada, is a biotechnology and life science industry association whose mission is to represent and promote the economic interests of the sector of biopharmaceutical. The organization represents more than 150 member companies and R&D centers in Quebec, and works to create a positive influence on the growth of the life science industry, including capital access, public policy, workforce development and international promotion. BIOQuebec's main role is to represent the voice of the bio-industry in Quebec.
For more information about BioQuébec, please go to: www.bioquebec.com
Cepmed is a non-profit organization dedicated to promoting the science and practice of personalized medicine through research, commercialization and education.It currently participates in several multi-million dollar public-private partnerships in translational medicine that incorporate pharmacogenetic testing into Phase III clinical trials and studies of marketed products.In addition, it funds strategic personalized medicine research projects with high commercialization potential and has embarked on a program to promote the principles of personalized medicine to healthcare practitioners and stakeholders across the country.
For more information about Cepmed, please go to: www.cepmed.com
Génome Québec is a private not-for-profit organization with the mission of supporting and spurring on genomics research through the funding of structuring research initiatives and the implementation of programs designed to integrate research results into the health and natural resource sectors. Génome Québec has, since its inception, funded 40 major projects representing a total value to date of nearly half a billion dollars.
For more information about Génome Québec, please go to: www.genomequebec.com
The Canadian Institute for Photonics Innovation (CIPI) is a Network of Centers of Excellence. Its pan-Canadian mission is to bring university researchers together with public sector and industrial partners in a network with state-of-the-art facilities in order to stimulate world-class innovations in photonics and to promote their exploitation to generate wealth and enhance the quality of life for Canadians. CIPI carries out its mission in particular through networking activities and financing programs. Research projects that address the mission of both CQDM and CIPI could receive complementary funding.
For more information about CIPI, please go to: www.cipi.ulaval.ca
Montréal International (MI) is a non-profit organization created in 1996 as a result of a private-public partnership. Its mission is to contribute to the economic development of Greater Montréal and enhance its international status. MI is financed by some 100 members from the private and institutional sectors, as well as the Governments of Canada and Québec, the Communauté métropolitaine de Montréal and the City of Montréal. Principals mandates are: Attract, retain and expand foreign direct investment, attract, retain and expand international organizations, attract, welcome and retain foreign talent and finally promote and reinforce Greater Montréal’s economic attractiveness and international status.
For more information about Montréal International, please go to: www.montrealinternational.com
Montréal InVivo, a non-profit organization, is the brand name for the life sciences and health technologies cluster of the Montréal metropolitan area. The cluster is comprised of more than 620 organizations, including 150 research organizations, and 80 subsidiaries of foreign companies. It is a fertile breeding ground for innovation and creativity. This creative cluster is supported by 11 institutions of higher education and it is ranked 1st in Canada in terms of the number of research centres and total university research funding. The cluster is also unique in Canada, and is one of the few places in the world, where a company can conduct every phase of creation of a new drug, from basic research through to commercialization. The cluster provides a productive environment for every company in the life sciences and health technologies.
For more information about Montréal InVivo, please go to: www.montreal-invivo.com
MSBiV: Investing to speed-up the monetization of highly promising technologies.Partner institutions include McGill University, Université de Sherbrooke and Bishop's University, as well as their affiliated hospitals, research institutes and technology transfer entities. MSBiV brings industry knowledge and relationships to the existing effort of bridging the gap between discoveries resulting from university research and the marketplace.
for more information about MSBiV, please go to: www.msbiv.ca
Pharmabio Développement, Sectoral Committee of workforce of pharmaceutical and biotechnology industries of Quebec, is a non-profit corporation, which gathers representatives of employers associations, businesses, unions and government agencies. Pharmabio Development is a place of dialogue and mobilization of different actors of the industry in improving and maintains the skills of workers in the industry. Pharmabio Development also works to stimulate youth interest in science to ensure the succession for the pharmaceutical industry and biotechnology.
For more information about Pharmabio Development, please go to: www.pharmabio.qc.ca
Univalor is a limited partnership founded in 2001 whose mission is to accelerate the transfer to industry of the results of research undertaken by researchers from the Université de Montréal, its affiliated schools and most of its affiliated hospitals. Univalor brings together experienced professionals. Weestablish profitable long term business relationships with companies and associates. Univalor offers to partners the opportunity to increase their competitive advantage through access toleading edge scientific and engineering technologies developed by world classresearchers. Our current portfolio consists of approximately 300 technological inventions transferable to industry.
For more information about Univalor, please go to: www.univalor.ca
Through unique research and training programs, Mitacs is developing the next generation of innovators with vital scientific and business skills. In partnership with companies, government and academia, Mitacs is supporting a new economy using Canada’s most valuable resource – its people. *Mitacs is a national, not-for-profit research organization.
For more information about Mitacs, please go to: www.mitacs.ca
Accredited as a World Class Competitiveness Cluster in 2005, Lyonbiopole, a center of excellence for vaccines and diagnostics based in Lyon, focuses on the fight against human and animal infectious diseases and cancers. It aims to increase the competitiveness of the healthcare companies and the appeal of the Rhone-Alpes region territory, namely in the Lyon-Grenoble area. As an intermediary between the public and private sectors, the cluster works to encourage collaboration in R&D, to assist in the project building, to seek funding, to increase strategic and financial partnerships for the economic and international development of companies, and to provide access to project hosting facilities and shared technological platforms such as Lyonbiopole’s Infectious Diseases Center, which opened on 1 April 2009.
Launched in November 2010, the OBI has been established to become an internationally recognized centre of excellence in brain research, translation and innovation. It will achieve its vision by initiating, funding, promoting and stimulating brain research, education and training. The research outcomes will be translated into clinical applications and commercialization opportunities related to the prevention, early diagnosis, treatment and management of brain diseases and disorders. The Institute is an independent, not-for-profit corporation funded by the Government of Ontario. The OBI will serve as a nexus for collaborative efforts, with a program focused on bringing together Ontario's leading scientists and clinicians drawn from Ontario's universities, colleges, and hospitals.
For more information about the OBI, visit:http://www.braininstitute.ca
MaRS Innovation (MI) is the commercialization agent for the exceptional discovery pipeline from 16 leading Ontario academic institutions. As a single-entry point to total member research activity of $1B in annual research and development, MI provides an easy gateway for investors and licensees who wish to gain access to technology assets in Ontario. Supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its member institutions, MI is a transformational partnership that turns research strengths into real commercial opportunities. MI’s portfolio includes the most promising assets and advances commercialization into global markets through industry partnerships, licensing and company creation. www.marsinnovation.com
Ontario Centres of Excellence (OCE) drives the commercialization of cutting-edge research across key market sectors to build the economy of tomorrow and secure Ontario's global competitiveness. In doing this, OCE fosters the training and development of the next generation of innovators and entrepreneurs and is a key partner with Ontario's industry, universities, colleges, research hospitals, investors and governments. A champion of leading-edge technologies, best practices and research, OCE invests in sectors such as advanced health, digital media and information communications, advanced manufacturing and materials, and cleantech including energy, environment and water. OCE through its Centre for Commercialization of Research (CCR), an initiative supported by the federal government, also acts as a catalyst which allows innovative businesses to grow and achieve sustainable commercial success and global competitiveness. OCE is a key partner in delivering Ontario's Innovation Agenda as a member of the province's Ontario Network of Excellence (ONE). Funded by the Government of Ontario, the ONE is Ontario's innovation system. The ONE is made up of regional and sector focused organizations designed to help Ontario-based entrepreneurs rapidly grow their companies, and create jobs.
For more information visit www.oneinnovation.ca.